骨肌肉中的肌肉胆受体:定位和功能性作用
I V Kovyazina1,2, A A Khamidullina1
1Kazan State Medical University, Kazan, 420012 Russian Federation.
Acta naturae
|January 18, 2024
概括
骨肌肉中的肌肉受体不仅调节神经信号;它们还影响突触发育和结构. 了解这些复杂的角色和信号通路对于神经肌肉传播研究至关重要.
科学领域:
- 神经科学是一个神经科学.
- 肌肉生理学 肌肉生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肌肉胆受体与神经肌肉传播有关,但它们在骨肌肉中的精确功能和信号通路仍然不完全理解.
- 虽然在历史上与神经分泌有关,但肌肉蛋白受体的作用延伸到突触发育和适应肌肉活动.
研究的目的:
- 审查肌肉胆因受体在骨肌肉中的功能,专注于神经肌肉接触的现代概念.
- 阐明各种动物群体的骨肌肉中由肌肉蛋白受体亚型激活的信号通路.
- 分析在运动突触中的肌肉蛋白受体作用研究中的方法和解释挑战.
主要方法:
- 对现代概念和研究方法的文献综述.
- 关于运动突触中的肌肉蛋白受体功能的实验数据的分析.
- 检查介导肌肉效应的细胞内机制和信号通路.
主要成果:
- 骨肌中的肌肉受体功能包括神经分泌调节,突触器官发育和形态适应.
- 多种不同的肌肉蛋白受体亚型参与了冷血和热血动物的骨肌肉生理学.
- 细胞内信号通路是肌肉类药物对神经肌肉传播的影响的关键调解者.
结论:
- 骨肌中的肌受体的功能是多方面的,超越神经分泌,延伸到突触可塑性.
- 需要进一步的研究,以充分阐明骨肌肉中肌肉受体的复杂调节作用和细胞内机制.
- 了解这些途径对于进一步了解神经肌肉功能和潜在的治疗干预措施至关重要.
更多相关视频
10:50Muscle Receptor Organs in the Crayfish Abdomen: A Student Laboratory Exercise in Proprioception
Published on: November 18, 2010
22.4K
08:12Author Spotlight: Isolation of Long Muscle Fibers from Mouse Hindlimb Muscles for Studying Excitation-Contraction Coupling Across Fiber Types
Published on: December 1, 2023
2.0K
相关概念视频
Cholinergic Receptors: Muscarinic
2.3K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.3K
Cholinergic Receptors: Nicotinic
2.8K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
2.8K
Parasympathetic Signaling
1.9K
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...
1.9K
Muscle Contraction
6.4K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
6.4K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
978
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
978
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
